Davis's Drug Guide
CISplatin
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Pronunciation:
sis-pla-tin
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Platinol
Ther. Class.
Pharm. Class.
alkylating agents
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "CISplatin." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. www.drugguide.com/ddo/view/Davis-Drug-Guide/51156/all/CISplatin.
Vallerand AHA, Sanoski CAC, Quiring CC. CISplatin. Davis's Drug Guide. F.A. Davis Company; 2023. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/51156/all/CISplatin. Accessed December 9, 2023.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). CISplatin. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/51156/all/CISplatin
Vallerand AHA, Sanoski CAC, Quiring CC. CISplatin [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2023 December 09]. Available from: https://www.drugguide.com/ddo/view/Davis-Drug-Guide/51156/all/CISplatin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - CISplatin
ID - 51156
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://www.drugguide.com/ddo/view/Davis-Drug-Guide/51156/all/CISplatin
PB - F.A. Davis Company
ET - 18
DB - Davis's Drug Guide
DP - Unbound Medicine
ER -